Collegium Pharmaceutical announced a headquarters milestone on July 20, 2026. Collegium Pharmaceutical plans to move its corporate headquarters from Stoughton to One Lincoln in downtown Boston during the first quarter of 2027.

What changed

The announcement changes the company’s headquarters footprint from Stoughton, MA to Boston, MA. The planned office will support the company’s evolving biopharmaceutical portfolio and provide a central environment for its teams to work together.

New headquarters: One Lincoln, Boston, MA
Previous headquarters: Stoughton, MA
Announcement date: July 20, 2026

Why the company chose this location

Collegium cited access to Boston’s scientific, academic, healthcare, and business communities while reaffirming its long-term commitment to Massachusetts.

What the move signals

A headquarters opening or relocation can signal new hiring capacity, consolidation of operating teams, investment in a regional ecosystem, or a change in how a company serves customers and partners. For GTM teams, the useful next step is to watch for role openings, regional leadership appointments, vendor consolidation, and facilities-related initiatives connected to the move.

Source and methodology

This profile uses the company or property owner’s announcement as its primary source. Future opening dates and planned occupancy are presented as announced and may change.

Primary source: Collegium Pharmaceutical company announcement.